Pacira BioSciences, Inc. reported preliminary unaudited revenue results for the year ended December 31, 2024. The company reported preliminary unaudited total revenue of $701.0 million for the year ended December 31, 2024, compared with $675.0 million for the year ended December 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.10 USD | -0.61% |
|
-0.87% | +38.54% |
Jan. 31 | North American Morning Briefing : Investors in -2- | DJ |
Jan. 30 | Pacira BioSciences, Inc. Announces Board and Audit Committee Changes | CI |

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Pacira BioSciences, Inc. Reports Preliminary Unaudited Revenue Results for the Year Ended December 31, 2024